Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -5.05% is in line with its 5-year average of -4.67%, around the middle of its 5-year range (-11.41%–4.68%).
28.17% above its 12-month average of -7.03%.
Reported quarterly return on assets; no daily interpolation. Q4 FY2025 (2025-12-31): -2.46%.
RETURN ON ASSETS (ROA)
-5.05%
RETURN ON ASSETS (ROA) AVG TTM
-7.03%
RETURN ON ASSETS (ROA) AVG 3Y
-4.31%
RETURN ON ASSETS (ROA) AVG 5Y
-4.67%
RETURN ON ASSETS (ROA) AVG 10Y
-9.24%
RETURN ON ASSETS (ROA) AVG 15Y
-8.47%
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+28.17%
CURRENT VS 3Y AVG
-17.03%
CURRENT VS 5Y AVG
-8.25%
CURRENT VS 10Y AVG
+45.32%
CURRENT VS 15Y AVG
+40.35%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-30.67%
median of 686 covered companies
CURRENT VS SECTOR MEDIAN
+83.54%
vs the sector median at left
InterCure Ltd.
Market Cap
$63.14M
Return on Assets (ROA)
-5.05%
TTM Avg
-7.03%
3Y Avg
-4.31%
5Y Avg
-4.67%
Market Cap
$63.23M
Return on Assets (ROA)
-39.17%
TTM Avg
-30.96%
3Y Avg
-31.81%
5Y Avg
-21.33%
Market Cap
$63.26M
Return on Assets (ROA)
-44.47%
TTM Avg
-42.63%
3Y Avg
-230.85%
5Y Avg
-167.04%
Market Cap
$63.78M
Return on Assets (ROA)
-48.60%
TTM Avg
-59.64%
3Y Avg
-46.49%
5Y Avg
-40.66%
Market Cap
$64.13M
Return on Assets (ROA)
-13.50%
TTM Avg
-6.86%
3Y Avg
-33.98%
5Y Avg
-45.40%
Market Cap
$61.21M
Return on Assets (ROA)
-66.80%
TTM Avg
-56.95%
3Y Avg
-50.95%
5Y Avg
-40.99%
Market Cap
$60.49M
Return on Assets (ROA)
-382.32%
TTM Avg
-98.02%
3Y Avg
-80.35%
5Y Avg
-65.77%
Market Cap
$60.32M
Return on Assets (ROA)
-98.94%
TTM Avg
-57.19%
3Y Avg
-57.75%
5Y Avg
-128.29%
Market Cap
$66.02M
Return on Assets (ROA)
-87.09%
TTM Avg
-130.17%
3Y Avg
-272.35%
5Y Avg
-217.34%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InterCure Ltd. (INCR) | $63.14M | -5.05% | -7.03% | -4.31% | -4.67% |
| Alps Group Inc (ALPS)vs › | $63.23M | -39.17% | -30.96% | -31.81% | -21.33% |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.26M | -44.47% | -42.63% | -230.85% | -167.04% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | -48.60% | -59.64% | -46.49% | -40.66% |
| Heron Therapeutics, Inc. (HRTX)vs › | $64.13M | -13.50% | -6.86% | -33.98% | -45.40% |
| Adicet Bio, Inc. (ACET)vs › | $61.21M | -66.80% | -56.95% | -50.95% | -40.99% |
| PDS Biotechnology Corporation (PDSB)vs › | $60.49M | -382.32% | -98.02% | -80.35% | -65.77% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $60.32M | -98.94% | -57.19% | -57.75% | -128.29% |
| Cingulate Inc. (CING)vs › | $66.02M | -87.09% | -130.17% | -272.35% | -217.34% |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.17M | -393.68% | -194.68% | -123.06% | -102.52% |
ROA
-5.0%
ROE
-8.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -5.17% |
| 2024-12-31 | -8.89% |
| 2023-12-31 | -7.88% |
| 2022-12-31 | 4.68% |
| 2021-12-31 | 0.68% |
| 2020-12-31 | -11.41% |
| 2019-12-31 | -2.09% |
| 2018-12-31 | -35.63% |
| 2017-12-31 | -21.96% |
| 2016-12-31 | 0.96% |
| 2015-12-31 | -14.88% |
| 2014-12-31 | -143.67% |
| 2013-12-31 | -107.17% |
| 2012-12-31 | 299.00% |
| 2011-12-31 | -232.97% |
| 2010-12-31 | 0.00% |
